131 related articles for article (PubMed ID: 15209386)
1. Inhibition of HLA-G production in JEG-3 choriocarcinoma cells by RNA interference.
Wengenmayer T; Poehlmann TG; Markert UR
Am J Reprod Immunol; 2004 Mar; 51(3):189-91. PubMed ID: 15209386
[TBL] [Abstract][Full Text] [Related]
2. Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro.
Yie SM; Li LH; Li GM; Xiao R; Librach CL
Hum Reprod; 2006 Jan; 21(1):46-51. PubMed ID: 16210391
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro.
Sun LL; Han Y; Chen JH; Yao YQ
Fertil Steril; 2008 Dec; 90(6):2398-405. PubMed ID: 18243178
[TBL] [Abstract][Full Text] [Related]
4. [Effects on human leukocyte antigen-G on proliferation and invasion of JEG-3 cell line].
Liu HY; Gu WR; Li XT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jun; 43(6):445-50. PubMed ID: 19035141
[TBL] [Abstract][Full Text] [Related]
5. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella ED; Moreau P
Cell Mol Life Sci; 2006 Nov; 63(22):2669-81. PubMed ID: 17072500
[TBL] [Abstract][Full Text] [Related]
6. Effect of progesterone on HLA-E gene expression in JEG-3 choriocarcinoma cell line.
Huang Z; Hyodo H; Fujii T; Nagamatsu T; Matsumoto J; Kawana K; Yamashita T; Yasugi T; Kozuma S; Taketani Y
Am J Reprod Immunol; 2009 Mar; 61(3):221-6. PubMed ID: 19239424
[TBL] [Abstract][Full Text] [Related]
7. [Role of human leukocyte antigen-G small interference RNA in a choriocarcinoma cell line].
Chen CL; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):549-52. PubMed ID: 16202295
[TBL] [Abstract][Full Text] [Related]
8. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines.
Rinke de Wit TF; Vloemans S; van den Elsen PJ; Haworth A; Stern PL
J Immunol; 1990 Feb; 144(3):1080-7. PubMed ID: 2104910
[TBL] [Abstract][Full Text] [Related]
10. Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
Sangrouber D; Marcou C; Le Discorde M; Chang CC; Carosella ED; Moreau P
J Immunol Methods; 2007 Sep; 326(1-2):54-62. PubMed ID: 17689555
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells.
Zhu XM; Han T; Wang XH; Li YH; Yang HG; Luo YN; Yin GW; Yao YQ
Am J Obstet Gynecol; 2010 Jun; 202(6):592.e1-7. PubMed ID: 20430358
[TBL] [Abstract][Full Text] [Related]
12. Ocular surface epithelial cells up-regulate HLA-G when expanded in vitro on amniotic membrane substrates.
Higa K; Shimmura S; Shimazaki J; Tsubota K
Cornea; 2006 Jul; 25(6):715-21. PubMed ID: 17077667
[TBL] [Abstract][Full Text] [Related]
13. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules.
Le Friec G; Gros F; Sebti Y; Guilloux V; Pangault C; Fauchet R; Amiot L
J Leukoc Biol; 2004 Dec; 76(6):1125-33. PubMed ID: 15331623
[TBL] [Abstract][Full Text] [Related]
14. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
15. HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1.
Moreau P; Paul P; Gourand L; Prost S; Dausset J; Carosella E; Kirszenbaum M
Hum Immunol; 1997 Jan; 52(1):41-6. PubMed ID: 9021408
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
17. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
18. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule.
Ellis SA; Palmer MS; McMichael AJ
J Immunol; 1990 Jan; 144(2):731-5. PubMed ID: 2295808
[TBL] [Abstract][Full Text] [Related]
19. HLA-G regulates the invasive properties of JEG-3 choriocarcinoma cells by controlling STAT3 activation.
Liu X; Gu W; Li X
Placenta; 2013 Nov; 34(11):1044-52. PubMed ID: 24054889
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.
Holling TM; Bergevoet MW; Wierda RJ; van Eggermond MC; van den Elsen PJ
Ann N Y Acad Sci; 2009 Sep; 1173():538-44. PubMed ID: 19758196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
